$INDP Up 40% — Low-Float Bio Momentum Heating Up 🚀 🔹 Indaptus Therapeutics is a clinical-stage biotech focused on cancer immunotherapy 🧬 🔹 Lead platform Dec

$INDP Up 40% — Low-Float Bio Momentum Heating Up 🚀 🔹 Indaptus Therapeutics is a clinical-stage biotech focused on cancer immunotherapy 🧬 🔹 Lead platform Decoy20 is designed to activate both innate & adaptive immune responses against tumors 🔥 🔹 Recent focus has been on strategic/financing uncer…